Clinical Trial Update: Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on Phase 1/2 studies of bendamustine and erlotinib in advanced breast cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bendamustine Hydrochloride (bendamustine)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-04-22